Companies/EU/IVA

INVENTIVA

Last · Paris€2.665-0.275 (-9.35%)close · yahoo · 19h ago
Vol 780.4K ≈ 2.06M
Market cap€629.5M236.2M sh
P/E · TTM-5.0fwd -4.5 · eps -0.53 · loss
Beta1.00vs S&P 500
Div yield0.00%annual · TTM
52w range
€2.57€6.20
Volume437.9Ksession

Issuer

Legal nameINVENTIVA
HQEurope (EU)
ListingEU IVA
ISINFR0013233012
SectorHealthcare
IndustryBiotechnology & Medical Research
CurrencyEUR
Entity registrylei:969500I9Y690B3FZW590
CIK0001756594
Employees73
AddressInventiva SA 50, rue de Dijon 21121, Daix +33 3 80 44 75 00
Headline financial metrics
Revenue€17.5M
Operating income€-102.7M
Net income€-110.4M
Free cash flow€-89.3M
Operating margin-587.7%
Net margin-631.8%
Period2023
Loading chart…

OpenFilings analyst

Our analyst

ANNUAL · 2026-04-08

From latest ANNUAL · 2026-04-08

  • Operating Cf Burn
  • Net Margin Sharply Negative

Red flags

  • Operating Cf Burn — Negative operating cash flow
  • Net Margin Sharply Negative — Net margin -7899.6%

Earnings transcripts

12 of 17 recent

Press & signals

3 of 7 recent
  • GlobeNewswire

    Inventiva to Present Multiple Abstracts at Paris MASH 2026

  • GlobeNewswire

    Inventiva Announces Last Patient Visit in NATiV3 Phase 3 Clinical Trial of Lanifibranor in MASH

  • GlobeNewswire

    Inventiva Appoints Chris Benecchi as Chief Operating Officer

The rest of this company's wire — with summaries and source links — is part of Pro.

See plans

Documents

FormReporting forFiledFlags
2026-10-122026-10-120
2026-10-092026-10-090